Sign in

METRICStanford

@metricstanford.bsky.social
69 followers 64 following 57 posts

METRICS is a research to action center focused on transforming research practices to improve the quality of scientific research in health and medicine. METRICS International Forum: metrics.stanford.edu/metrics-intern…

PostsRepliesMedia
METRICStanford @metricstanford.bsky.social · 15/07/2026
Yaacoub S, Ioannidis JPA, Hróbjartsson A, Porcher R, Ravaud P, Boutron I. Factors influencing the trustworthiness of non-randomized studies of interventions: a survey of international experts. BMC Med. 2026 Jul 2. doi:10.1186/s12916-026-04979-6,
link.springer.com
Factors influencing the trustworthiness of non-randomized studies of interventions: a survey of international experts - BMC Medicine
Background Perceived trustworthiness of research may be influenced by factors beyond the risk of bias, including study-related characteristics, research context, and external circumstances.…
000
METRICStanford @metricstanford.bsky.social · 14/07/2026
Biemond MJ, Putter H, Bastiaannet E, van der Vorst JR, Matsumura JS, Hamming JF, Ioannidis JPA, Lindeman JHN. Balancing Immediate Surgical Risks with Deferred Benefits in Preventive Surgery. Eur J Vasc Endovasc Surg. 2026. doi: 10.1016/j.ejvs.2026.06.049.
ejves.com
000
METRICStanford @metricstanford.bsky.social · 13/07/2026
Ioannidis JPA. Improving scientific research: renegotiated principles of science, proposals, failures, and successes. Eur J Clin Invest. 2026.
onlinelibrary.wiley.com
000
METRICStanford @metricstanford.bsky.social · 10/07/2026
Long COVID research often lacks controls and does not acknowledge this limitation: meta-epidemiological analysis. Antonios-Periklis Panagiotopoulos, Alexandros Laskaris, Deny Tsakri, Cleo Anastassopoulou, Athanasios Tsakris, John P. A. Ioannidis. medRxiv doi:
doi.org
010
METRICStanford @metricstanford.bsky.social · 09/07/2026
Malički M, Chandler Z, Goodman SN. Highlighting Rigor, Reproducibility, and Transparency of Research in an Academic CV. Clin Transl Sci. 2026 Jun;19(6):e70575. doi: 10.1111/cts.70575.
ascpt.onlinelibrary.wiley.com
Highlighting Rigor, Reproducibility, and Transparency of Research in an Academic CV
In academia, the curriculum vitae (CV) is the central document used for hiring, promotion, or tenure applications. The content and format of these CVs and accompanying documents varies among…
000
METRICStanford @metricstanford.bsky.social · 08/07/2026
Schippers MC, Vermeulen N, Ioannidis JPA. Misinformation blaming and labelling may damage health, science and policy making. Am J Med. 2026 May 22:S0002-9343(26)00415-8. doi: 10.1016/j.amjmed.2026.05.028.
amjmed.com
Misinformation blaming and labelling may damage health, science and policy making
Concerns about misinformation and disinformation have become central to debates in medicine and health, science, and public policy. Many people hold inaccurate beliefs about scientific evidence,…
000
METRICStanford @metricstanford.bsky.social · 07/07/2026
Pučić-Baković M, Štambuk T, Ioannidis JPA, Zoldoš V, Wang W, Lauc G. Large glycomics datasets as a tool to understand the function of glycans. Nat Chem Biol. 2026 May 22. doi: 10.1038/s41589-026-02217-x.
nature.com
Large glycomics datasets as a tool to understand the function of glycans - Nature Chemical Biology
Recent technological advances are enabling a growing number of large-scale glycomics studies. This Review discusses the challenges in high-throughput glycoanalytical methods with special attention to…
000
METRICStanford @metricstanford.bsky.social · 06/07/2026
Ioannidis JPA. fMRI research: do we need statistically better studies, larger studies, or no more studies? Cogn Neurosci. 2026 May 25:1-2. doi:10.1080/17588928.2026.2675936.
tandfonline.com
fMRI research: do we need statistically better studies, larger studies, or no more studies?
fMRI research is highly prolific but raises multiple concerns. Many competing statistical methods and respective packages are available using different assumptions, none of which applies equally we...
000
METRICStanford @metricstanford.bsky.social · 03/07/2026
Berthelsen DB, [...] Ioannidis JPA, [...] OMERACT Safety Working Group. Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases. Semin Arthritis Rheum. 2026 doi: 10.1016/j.semarthrit.2026.153026.
sciencedirect.com
000
METRICStanford @metricstanford.bsky.social · 02/07/2026
Zhang J, Fischer F, [...] Ioannidis JPA, [...] DEPRESSD HADS Collaboration. Comparison of the accuracy of latent factor and sum scoring of the Hospital Anxiety and Depression Scale to screen for major depression: An IPD meta-analysis. J Affect Disord. 2026.
sciencedirect.com
000
METRICStanford @metricstanford.bsky.social · 01/07/2026
Levitt M, Marten B, Oren G, Ioannidis JPA. Reclassification and weighting of multiple causes of death: US death certificates 2003-2023. Proc Natl Acad Sci U S A. 2026 Jun 23;123(25):e2604493123. doi: 10.1073/pnas.2604493123.
pnas.org
PNAS
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly…
000
METRICStanford @metricstanford.bsky.social · 30/06/2026
Russo L, Lentini N, Farina S, Cristiano A, Adduci A, Perilli A, Cao C, Pastorino R, Boccia S, Ioannidis JP. Effects of polygenic risk score communication on short term health outcomes: systematic review and meta-analysis. BMJ Med. 2026 Jun 12;5(1):e002347. bmjmedicine.bmj.com/content/5/1/...
bmjmedicine.bmj.com
000
METRICStanford @metricstanford.bsky.social · 26/05/2026
Russo L, Lentini N, Soru L, Pastorino R, Boccia S, Ioannidis JPA. Randomized trials of 'personalized', 'individualized' and 'precision' interventions are very diverse and have low transparency and high bias. J Clin Epidemiol. 2026. 10.1016/j.jclinepi.2026.112338.
jclinepi.com
Randomized trials of ‘personalized’, ‘individualized’ and ‘precision’ interventions are very diverse and have low transparency and high bias
The terms ‘personalized’, individualized’ and ‘precision’ are increasingly used to describe interventions, yet their operational meaning is often unclear. Despite extensive conceptual debate, no…
000
METRICStanford @metricstanford.bsky.social · 25/05/2026
Lyu C, Matbouriahi M, Naudet F, Ioannidis JPA, Cristea IA. Retracted Randomized Clinical Trials From Superretractors and Top-Cited Scientists With Multiple Retractions. JAMA Netw Open. 2026 Apr 1;9(4):e267424. doi:10.1001/jamanetworkopen.2026.7424.
jamanetwork.com
Retracted Randomized Clinical Trials From Authors With Multiple Retractions
This cohort study evaluates the author and publication characteristics of retracted randomized clinical trials.
000
METRICStanford @metricstanford.bsky.social · 22/05/2026
Berthelsen DB, Haugegaard T, Kamso MM, Tugwell P, Simon LS, Ioannidis JPA, [...], Hazlewood GS, Christensen R. Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis. Semin Arthritis Rheum. 2026 doi:10.1016/j.semarthrit.2026.152983.
sciencedirect.com
000
METRICStanford @metricstanford.bsky.social · 21/05/2026
von Klinggraeff L, Pfledderer CD [...], Ioannidis JPA, [...] Beets MW. Examining predictors of scale-up penalty in preliminary studies of health behavior interventions and subsequent larger trials: a meta-epidemiological review of diverse fields. 2026.
link.springer.com
Examining predictors of scale-up penalty in preliminary studies of health behavior interventions and subsequent larger trials: a meta-epidemiological review of diverse fields - Pilot and Feasibility Studies
Background Scale-up penalty, a common phenomenon in which the promising effects found in early preliminary studies are substantially reduced when evaluated in a subsequent larger trial, can stall the…
000
METRICStanford @metricstanford.bsky.social · 20/05/2026
Judge A, Beidelman ET, Allison DB, [...] Ioannidis JP, [...] Ludema C. How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA. BMJ Open. 2026 doi: 10.1136/bmjopen-2025-112893.
000
METRICStanford @metricstanford.bsky.social · 20/05/2026
Leichsenring F, Flückiger C, Heim N, Hoyer J, [...] Munder T, Sell C, Spitzer C, Steinert C, Ioannidis JPA. Interventions for common mental disorders tested in Cochrane reviews: an analysis of quality of evidence and efficacy. World Psychiatry. 2026 onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
000
METRICStanford @metricstanford.bsky.social · 29/04/2026
Student Scholarly Research Programs in US Medical Schools: Cross-sectional Web Audit. Dongyoon Lee, Changyoon Lee, Sarah Soyeon Oh, Keeheon Lee, Chul S Hyun, Jae Il Shin, Shinki An, John PA Ioannidis. medRxiv 2026.03.03.26347497; www.medrxiv.org/content/10.6...
doi.org
000
METRICStanford @metricstanford.bsky.social · 28/04/2026
Post-pandemic mortality patterns and COVID-19 burden considering multiple death causes. Uwe Riedmann, Michael Levitt, Stefan Pilz, John PA Ioannidis. www.medrxiv.org/content/10.1...
doi.org
000
METRICStanford @metricstanford.bsky.social · 27/04/2026
TrialScout links published results to trial registrations using a large language model. Love Ahnström, Till Bruckner, Darya Ava Aspromonti, Laura Caquelin, Jamie Cummins, Nicholas J. DeVito, Cathrine Axfors, John P.A. Ioannidis, Gustav Nilsonne. medRxiv 2026; doi:
doi.org
000
METRICStanford @metricstanford.bsky.social · 24/04/2026
Reclassification and Weighting of Multiple Causes of Death: US Death Certificates 2003-2023. Michael Levitt, Ben Marten, Gal Oren, John Ioannidis. medRxiv 2026.01.31.26345264; doi:
medrxiv.org
011
METRICStanford @metricstanford.bsky.social · 23/04/2026
Zhou C, Fabiano N, Gupta A, Wong S, Cobey KD, Moher D, Ebrahimzadeh S, Ng JY, Dragioti E, Shin JI, Radua J, Cortese S, Shea B, Veronese N, Hartling L, Ioannidis JPA, Solmi M. Guidance for umbrella reviews of observational studies: A scoping review. JCPP Adv. 2025 doi:10.1002/jcv2.70017
acamh.onlinelibrary.wiley.com
000
METRICStanford @metricstanford.bsky.social · 22/04/2026
Zavalis EA, Pezzullo AM, Ioannidis JPA. Instability of Global Burden of Disease Estimates of Deaths and Disability-Adjusted Life-Years From Major Risk Factors: A Meta-Epidemiological Analysis. JAMA Health Forum. 2026. doi: 10.1001/jamahealthforum.2026.0108,
jamanetwork.com
Instability of Global Burden of Disease Estimates of Deaths and DALYs
This meta-epidemiological assessment evaluates the reliability of the Global Burden of Disease risk factor estimates for mortality and disability-adjusted life-years.
020
METRICStanford @metricstanford.bsky.social · 21/04/2026
Henssler JF, Reis-Pardal J, Koppel L, Ioannidis JPA. Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects for Continuous Outcomes in Abstracts. J Clin Epidemiol. 2026 doi: 10.1016/j.jclinepi.2026.112215,
jclinepi.com
Trustworthiness and transparency features were less frequent in randomized trials presenting large effects for continuous outcomes in abstracts
Large effect sizes (ESs), especially when prominently presented in trial abstracts, draw large attention, but it is important to understand whether they are trustworthy. We aimed to assess indicators…
010
METRICStanford @metricstanford.bsky.social · 20/04/2026
Patel CJ, Ioannidis JPA, Manrai AK. An atlas of exposome-phenome associations in health and disease risk. Nat Med. 2026 Mar 18. doi:10.1038/s41591-026-04266-0,
nature.com
An atlas of exposome–phenome associations in health and disease risk - Nature Medicine
An exposome-wide association study of 619 exposures and 305 quantitative phenotypes shows that blood lipids, persistent pollutants and vitamin E are key contributors to phenotypic health traits.
000
METRICStanford @metricstanford.bsky.social · 20/04/2026
Seehra J, Pandis N, Ioannidis J. The Food and Drug Administration approval and clearance process for orthodontic devices. Am J Orthod Dentofacial Orthop. 2026 Apr;169(4):544-548. doi: 10.1016/j.ajodo.2026.01.008, www.ajodo.org/article/S088...
ajodo.org
The Food and Drug Administration approval and clearance process for orthodontic devices
The development of health care products and devices that could benefit patient care is underpinned by industry and manufacturer innovation. In the United States, the Food and Drug Administration…
000
METRICStanford @metricstanford.bsky.social · 06/03/2026
Non-genetic risk indicators for preterm birth: An umbrella review. J. Klumper, L. van Gils, R. van Doornik, [...] B.W.J. Mol, J.P.A. Ioannidis, J. van ’t Hooft. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2026.
sciencedirect.com
010
METRICStanford @metricstanford.bsky.social · 05/03/2026
Randomized controlled trials claiming “personalized”, “individualized” and “precision” interventions: characteristics, transparency and bias. Luigi Russo, Nicolò Lentini, Luisa Soru, Roberta Pastorino, Stefania Boccia, John PA Ioannidis. medRxiv 2026.02.09.26345904; doi:
doi.org
Randomized controlled trials claiming “personalized”, “individualized” and “precision” interventions: characteristics, transparency and bias
The terms personalized, individualized and precision medicine are increasingly used to describe health interventions, yet their operational meaning in clinical research remains unclear. Despite…
000
METRICStanford @metricstanford.bsky.social · 04/03/2026
Retracted randomized trials from super-retractors and top-cited scientists with multiple retractions. Chunwei Lyu, Minoo Matbouriahi, Florian Naudet, John P.A. Ioannidis, Ioana Alina Cristea. medRxiv 2025.11.23.25340834; doi:
doi.org
Retracted randomized trials from super-retractors and top-cited scientists with multiple retractions
Importance Multiple retractions from the same author often uncover issues affecting their entire work, such as having systematically altered or fabricated data. Objectives Evaluate the contribution…
000
METRICStanford @metricstanford.bsky.social · 02/03/2026
Ioannidis JPA, Baas J. Most science is published from countries lacking in democracy and freedom of press. Res Integr Peer Rev. 2026 Feb 5;11(1):4. doi:10.1186/s41073-026-00190-6.
link.springer.com
Most science is published from countries lacking in democracy and freedom of press - Research Integrity and Peer Review
Background Democracy and freedom of press may affect how science is prioritized, produced, communicated and disseminated. We aimed to map the production of scientific publications worldwide in terms…
000
METRICStanford @metricstanford.bsky.social · 27/02/2026
Levitt M, Marten B, Oren G, Ioannidis JPA. Reclassification and Weighting of Multiple Causes of Death: US Death Certificates 2003-2023. medRxiv [Preprint]. 2026 Feb 3:2026.01.31.26345264. doi: 10.64898/2026.01.31.26345264. www.medrxiv.org/content/10.6...
medrxiv.org
Reclassification and Weighting of Multiple Causes of Death: US Death Certificates 2003–2023
In death certificates Entity Axis reflects reported death causes in their original order, and Record Axis reflects standardized re-classifications processed with expert rules. Additionally, while…
000
METRICStanford @metricstanford.bsky.social · 04/02/2026
Science-wide mapping and ranking of institutions based on affiliated authors' impact and research integrity indicators. John Ioannidis, Jeroen Baas, Roy Boverhof, Cyril Voyant. doi: doi.org/10.64898/202... (version 2, revised).
doi.org
Science-wide mapping and ranking of institutions based on affiliated authors' impact and research integrity indicators
Background: Evaluation of institutions typically try to measure impact in various ways but pay little or no attention to research integrity and adjustment for institutional size. Here, we aimed to generate...
000
METRICStanford @metricstanford.bsky.social · 03/02/2026
Evolution of Reporting P-values Across the Biomedical Literature, 1990-2025: an Updated Meta-Research Study. Jinhyeok Choi, Keeheon Lee, David Chavalarias, Jae Il Shin, John P A Ioannidis. medRxiv 2026.01.14.26344149; doi:
doi.org
Evolution of Reporting P-values Across the Biomedical Literature, 1990-2025: an Updated Meta-Research Study
Importance Over several decades there have been extensive debates on the use and misuse of statistical significance. It would be important to capture what P -values are reported in biomedical papers…
000
METRICStanford @metricstanford.bsky.social · 30/01/2026
Science Journalism and advocacy: disseminating, facilitating, defending, shaping, terrorizing, or usurping science? SSRN 2025
dx.doi.org
<p>Science Journalism and Advocacy: Disseminating, Facilitating, Defending, Shaping, Terrorizing, or Usurping Science?</p>
<p><span>Science journalism has an illustrious history of service to science and society but has also faced many challenges in its mission. Diverse types of sci
000
METRICStanford @metricstanford.bsky.social · 29/01/2026
Glisic M, Llane A, Stojic S, Llanaj E, Roa-Díaz ZM, Raguindin PF, Kastrati L, Weed L, Turakhia MP, Ashley E, Muka T, Ioannidis JPA. An umbrella review of systematic reviews of the impact of wrist-worn wearables on health outcomes. Physiol Rev. 2025 Dec 29.
journals.physiology.org
An umbrella review of systematic reviews of the impact of wrist-worn wearables on health outcomes | Physiological Reviews | American Physiological Society
We conducted an umbrella review to synthesize the evidence on the effectiveness of interventions incorporating wrist-worn wearables' feedback on diverse health outcomes including health promotion…
000
METRICStanford @metricstanford.bsky.social · 28/01/2026
Kent DM, Ioannidis JPA. Adversarial Collaboration as a Strategy for Credible Biomedical Science. JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.23911. jamanetwork.com/journals/jam...
jamanetwork.com
Validate User
000
METRICStanford @metricstanford.bsky.social · 27/01/2026
Factors influencing the trustworthiness of non-randomized studies of interventions: a scoping review. Idowu Adegboye, Isabelle Boutron, Carolina Graña Possamai, John P.A. Ioannidis, Asbjørn Hróbjartsson, Raphaël Porch. MetaArXiv 2025,
osf.io
OSF
Background: Risk of bias assessment tools like ROBINS-I have been developed to identify biases in non-randomized studies of interventions. However, additional factors related to study design, reporting,...
000
METRICStanford @metricstanford.bsky.social · 26/01/2026
Most science is published from countries lacking in democracy and freedom of press. John P.A. Ioannidis, Jeroen Baas. bioRxiv 2025.07.03.663115; doi:
doi.org
Most science is published from countries lacking in democracy and freedom of press
Background Democracy and freedom of press may affect how science is prioritized, produced, communicated and disseminated. We aimed to map the production of scientific publications worldwide in terms…
000
METRICStanford @metricstanford.bsky.social · 23/01/2026
Retracted randomized trials attributed to super-retractors and top-cited scientists with multiple retractions: secondary analysis of the VITALITY retrospective cohort. Chunwei Lyu, Minoo Matbouriahi, Florian Naudet, John P.A. Ioannidis, Ioana Alina Cristea. medRxiv; doi:
doi.org
Retracted randomized trials attributed to super-retractors and top-cited scientists with multiple retractions: secondary analysis of the VITALITY retrospective cohort
Importance Multiple retractions from the same author often uncover issues affecting their entire work, such as having systematically altered or fabricated data. Objectives Evaluate the contribution…
000
METRICStanford @metricstanford.bsky.social · 22/01/2026
Malički M, Nachev V, Wieschowski S, ... , Carlisle BG, Franzen DL, Salholz-Hillel M, Goodman SN, Strech D. Registration and reporting of clinical trials affiliated with California universities and with primary completion date from 2014 to 2017. Trials. 2025.
link.springer.com
Registration and reporting of clinical trials affiliated with California universities and with primary completion date from 2014 to 2017 - Trials
Background Public information on US clinical trials is shared through the ClinicalTrials.gov registry. This study’s goal was to determine prospective registration, results reporting, trial…
000
METRICStanford @metricstanford.bsky.social · 21/01/2026
Panagiotopoulos AP, Anastassopoulou C, Tsakris A, Ioannidis JPA. Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs. Clin Infect Dis. 2025 Nov 25:ciaf648. doi: 10.1093/cid/ciaf648.
academic.oup.com
Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs
Pandemic preparedness has focused overwhelmingly on vaccines, leaving antivirals development underfunded, delayed, and fragmented. Drawing on COVID-19 less
000
METRICStanford @metricstanford.bsky.social · 20/01/2026
Gosling CJ, Garcia-Argibay M, De Prisco M, Arrondo G, Ayrolles A, Antoun S, Caparos S, ... , Cortese S. Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. BMJ. 2025 Nov 26;391:e085875. doi: 10.1136/bmj-2025-085875.
bmj.com
000
METRICStanford @metricstanford.bsky.social · 19/01/2026
Parish A, Ioannidis JPA, Zhang K, Barardo D, R Swindell W, de Magalhães JP. Reporting quality, effect sizes, and biases for aging interventions: a methodological appraisal of the DrugAge database. NPJ Aging. 2025 Nov 27;11(1):96. doi: 10.1038/s41514-025-00287-0.
nature.com
Reporting quality, effect sizes, and biases for aging interventions: a methodological appraisal of the DrugAge database - npj Aging
npj Aging - Reporting quality, effect sizes, and biases for aging interventions: a methodological appraisal of the DrugAge database
000
METRICStanford @metricstanford.bsky.social · 16/01/2026
Terré A, Becker O, Ioannidis JPA, Naudet F. Concordance between European medicine agency good clinical practice inspections and medical literature: a meta-research survey. BMC Med. 2025 Dec 3;23(1):674. doi:10.1186/s12916-025-04499-9.
link.springer.com
Concordance between European medicine agency good clinical practice inspections and medical literature: a meta-research survey - BMC Medicine
Background Health authorities, such as the European Medicines Agency (EMA), inspect clinical sites performing clinical trials and occasionally find evidence of substantial departures from Good…
000
METRICStanford @metricstanford.bsky.social · 15/01/2026
Science-wide mapping and ranking of institutions based on affiliated authors. John Ioannidis, Jeroen Baas, Roy Boverhof, Cyril Voyant. bioRxiv 2025.12.16.694665; doi: doi.org/10.64898/202...
doi.org
Science-wide mapping and ranking of institutions based on affiliated authors
Standardized information on the size of institutions and on their concentration of high-impact scientists is missing. Here, we generate institution-level data on 6,979 institutions with >=50 authors…
021
METRICStanford @metricstanford.bsky.social · 05/12/2025
Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts. Jonathan F. Henssler, Joana Reis-Pardal, Lina Koppel, John P.A. Ioannidis. medRxiv 2025.10.20.25338369; doi:
doi.org
Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts
OBJECTIVES Large effect sizes (ESs), especially when prominently presented in trial abstracts, draw large attention, but it is important to understand whether they are trustworthy. We aimed to assess…
000
METRICStanford @metricstanford.bsky.social · 04/12/2025
Effects of polygenic risk score communication on health outcomes: systematic review and meta-analysis. Luigi Russo, Nicolò Lentini, Sara Farina, Antonio Cristiano, Andrea Adduci, Alessio Perilli, Christian Cao, Roberta Pastorino, Stefania Boccia, JPA Ioannidis. medRxiv 2025
doi.org
Effects of polygenic risk score communication on health outcomes: systematic review and meta-analysis
Objective The purpose of this systematic review and meta-analysis is to summarize evidence from all RCTs to-date on the efficacy of polygenic risk score (PRS) communication in changing health…
000
METRICStanford @metricstanford.bsky.social · 03/12/2025
The architecture of exposome-phenome associations. Chirag J Patel, John PA Ioannidis, Arjun K Manrai. medRxiv 2025.06.05.25329055; doi:
doi.org
The architecture of exposome-phenome associations
Non-genetic exposures—including nutrients, lifestyle factors, consumables, and pollutants—contribute substantially to phenotypic variation. Most studies assess only a few candidate exposures or…
000
METRICStanford @metricstanford.bsky.social · 02/12/2025
Instability of Global Burden of Disease Estimates of Deaths and DALYs from Major Risk Factors. Emmanuel A. Zavalis, Angelo Maria Pezzullo, John P.A. Ioannidis. medRxiv 2025.11.14.25340145; doi:
doi.org
Instability of Global Burden of Disease Estimates of Deaths and DALYs from Major Risk Factors
Importance The Global Burden of Disease (GBD) study provides widely used estimates of mortality and disability-adjusted life years (DALYs) attributable to risk factors. Objective To evaluate the…
000